Literature DB >> 19387832

Effects of antidepressant treatment on antiretroviral regimen adherence among depressed HIV-infected patients.

Virender Kumar1, William Encinosa.   

Abstract

This study examined whether the relationship between HAART medication adherence and antidepressant treatment varied with HAART regimen complexity. The analysis included 1,192 respondents to the HIV Cost and Service Utilization Study (HCSUS) who were taking HAART. Self-reported past-week HAART adherence, antidepressant use, current mental health status, and an aggregate measure of regimen complexity were used in the analysis. Regression models with interactions between antidepressant treatment of mental health problems, poor emotional well-being or depressive symptoms, and medication complexity were estimated to assess differential associations with adherence. Irrespective of antidepressant treatment, poor mental health status was negatively associated with HAART medication adherence. However, only untreated higher depressive symptoms were strongly associated with maladherence to HAART medication (OR = 0.72 at P < 0.05). Medication complexity was strongly associated with maladherence to HAART medication (OR = 0.96 with P < 0.05) in the model including emotional well-being; and weakly associated with maladherence (OR = 0.97 and P < 0.07) in the model including depressive and/or anxiety symptoms. However, as HAART medication complexity increased, adherence was higher among individuals with poorer mental health but using antidepressants compared to those with better mental health (OR = 1.09 with P < 0.05 in the model including emotional well-being; OR = 1.09 and P < 0.05 in the model including depressive and/or anxiety symptoms), and compared to those with poorer mental health but not using antidepressants (OR = 1.09, P = 0.08 in the model including emotional well-being, and OR = 1.12, P < 0.05 in model including depressive and/or anxiety symptoms). In conclusion, while individuals with poorer mental health generally have poor HAART adherence, their adherence improved with the use of antidepressants as the HAART complexity increased.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19387832     DOI: 10.1007/s11126-009-9100-z

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  26 in total

Review 1.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

2.  Meta-analysis of the relationship between HIV infection and risk for depressive disorders.

Authors:  J A Ciesla; J E Roberts
Journal:  Am J Psychiatry       Date:  2001-05       Impact factor: 18.112

3.  The Antiretroviral Regimen Complexity Index. A novel method of quantifying regimen complexity.

Authors:  Staci Martin; Pamela L Wolters; Sarah K Calabrese; Mary Anne Toledo-Tamula; Lauren V Wood; Gregg Roby; Deborah K Elliott-DeSorbo
Journal:  J Acquir Immune Defic Syndr       Date:  2007-08-15       Impact factor: 3.731

4.  Barriers to antiretroviral adherence: the importance of depression, abuse, and other traumatic events.

Authors:  Michael Mugavero; Jan Ostermann; Kathryn Whetten; Jane Leserman; Marvin Swartz; Dalene Stangl; Nathan Thielman
Journal:  AIDS Patient Care STDS       Date:  2006-06       Impact factor: 5.078

5.  Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse.

Authors:  Charles H Hinkin; David J Hardy; Karen I Mason; Steven A Castellon; Ramani S Durvasula; Mona N Lam; Marta Stefaniak
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

6.  Cognitive functioning in a population-based sample of young adults with a history of non-psychotic unipolar depressive disorders without psychiatric comorbidity.

Authors:  A E Castaneda; J Suvisaari; M Marttunen; J Perälä; S I Saarni; T Aalto-Setälä; H Aro; S Koskinen; J Lönnqvist; A Tuulio-Henriksson
Journal:  J Affect Disord       Date:  2008-02-14       Impact factor: 4.839

7.  Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons.

Authors:  Adriana Ammassari; Andrea Antinori; Maria Stella Aloisi; Maria Paola Trotta; Rita Murri; Luca Bartoli; Antonella D'Arminio Monforte; Albert W Wu; Fabrizio Starace
Journal:  Psychosomatics       Date:  2004 Sep-Oct       Impact factor: 2.386

8.  Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients.

Authors:  Michael Alan Horberg; Michael Jonah Silverberg; Leo Bartemeier Hurley; William James Towner; Daniel Benjamin Klein; Susan Bersoff-Matcha; Winkler Gabriel Weinberg; Diana Antoniskis; Miguel Mogyoros; Wayne Thomas Dodge; Robert Dobrinich; Charles Price Quesenberry; Drew Anthony Kovach
Journal:  J Acquir Immune Defic Syndr       Date:  2008-03-01       Impact factor: 3.731

9.  Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity.

Authors:  C H Hinkin; S A Castellon; R S Durvasula; D J Hardy; M N Lam; K I Mason; D Thrasher; M B Goetz; M Stefaniak
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

10.  Effects of pharmacological therapy on gait and cognitive function in depressed patients.

Authors:  Diana Paleacu; Agatha Shutzman; Nir Giladi; Talia Herman; Ely S Simon; Jeffrey M Hausdorff
Journal:  Clin Neuropharmacol       Date:  2007 Mar-Apr       Impact factor: 1.592

View more
  18 in total

1.  Benefits of adherence to psychotropic medications on depressive symptoms and antiretroviral medication adherence among men and women living with HIV/AIDS.

Authors:  Dean G Cruess; Seth C Kalichman; Christine Amaral; Connie Swetzes; Chauncey Cherry; Moira O Kalichman
Journal:  Ann Behav Med       Date:  2012-04

2.  HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence.

Authors:  David J Moore; Carolina Posada; Mili Parikh; Miguel Arce; Florin Vaida; Patricia K Riggs; Ben Gouaux; Ronald J Ellis; Scott L Letendre; Igor Grant; J Hampton Atkinson
Journal:  AIDS Behav       Date:  2012-11

3.  Depression and poor adherence to lipid-lowering medications among patients with coronary artery disease.

Authors:  Roy C Ziegelstein; Brian Howard
Journal:  J Psychosom Res       Date:  2010-06-12       Impact factor: 3.006

Review 4.  Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011.

Authors:  Cathy M Puskas; Jamie I Forrest; Surita Parashar; Kate A Salters; Angela M Cescon; Angela Kaida; Cari L Miller; David R Bangsberg; Robert S Hogg
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

Review 5.  Psychosocial risk and management of physical diseases.

Authors:  Neil Schneiderman; Roger C McIntosh; Michael H Antoni
Journal:  J Behav Med       Date:  2019-01-10

6.  Self-reported medication adherence and symptom experience in adults with HIV.

Authors:  Caryl Gay; Carmen J Portillo; Ryan Kelly; Traci Coggins; Harvey Davis; Bradley E Aouizerat; Clive R Pullinger; Kathryn A Lee
Journal:  J Assoc Nurses AIDS Care       Date:  2011-03-05       Impact factor: 1.354

7.  Mental health treatment to reduce HIV transmission risk behavior: a positive prevention model.

Authors:  Kathleen J Sikkema; Melissa H Watt; Anya S Drabkin; Christina S Meade; Nathan B Hansen; Brian W Pence
Journal:  AIDS Behav       Date:  2010-04

8.  A qualitative analysis of the effects of depression and antidepressants on physical and work functioning among antiretroviral therapy clients in Uganda.

Authors:  Victoria K Ngo; Glenn J Wagner; Alexis Huynh; Gery Ryan; Seggane Musisi
Journal:  J Int Assoc Provid AIDS Care       Date:  2013-02-26

9.  Depression treatment enhances adherence to antiretroviral therapy: a meta-analysis.

Authors:  Nancy L Sin; M Robin DiMatteo
Journal:  Ann Behav Med       Date:  2014-06

10.  Facilitators of HIV Medical Care Engagement Among Former Prisoners.

Authors:  Natalie Bracken; Charles Hilliard; William J McCuller; Nina T Harawa
Journal:  AIDS Educ Prev       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.